T. Rowe Price
Overview
T. Rowe Price is a publicly owned global investment management firm that offers funds, subadvisory services, and separate account management for individuals, institutions, and financial intermediaries, with a focus on active management and a growth stock philosophy.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Anthropic | May 2026 | Series H | Co-investor |
| SiFive | Apr 2026 | Series G | Co-investor |
| OpenAI | Mar 2026 | Growth Equity | Lead |
| Candid Therapeutics | Mar 2026 | PIPE | Co-investor |
| Third Arc Bio | Feb 2026 | Series A Extension | Co-investor |
Key People
Gagandeep singh
Co-Founder
Mary Gammage
Managing Director
Randall Ferguson
Managing Director
Jessica Hiebler
Director Of Financial Reporting - Principal Accounting Officer
Tom Baxter
Director, Investor Education
Adam Marden
Portfolio Manager
Chris Faulkner-MacDonagh
Portfolio Manager
Chris Vost
Portfolio Manager
Christina Dove Noonan
Portfolio Manager
Christopher Brown
Portfolio Manager
Dante Pearson
Portfolio Manager
don peters
Portfolio Manager
Greg McCrickard
Portfolio Manager
Hari Balkrishna
Portfolio Manager
Jason Collins
Portfolio Manager
Jeff Rottinghaus
Portfolio Manager
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
